CN111344281B - 取代苯并咪唑类的钾通道抑制剂 - Google Patents

取代苯并咪唑类的钾通道抑制剂 Download PDF

Info

Publication number
CN111344281B
CN111344281B CN201880065901.5A CN201880065901A CN111344281B CN 111344281 B CN111344281 B CN 111344281B CN 201880065901 A CN201880065901 A CN 201880065901A CN 111344281 B CN111344281 B CN 111344281B
Authority
CN
China
Prior art keywords
alkyl
amino
phenyl
trifluoromethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880065901.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN111344281A (zh
Inventor
U·S·瑟伦森
A·梅特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACESION PHARMA APS
Original Assignee
ACESION PHARMA APS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ACESION PHARMA APS filed Critical ACESION PHARMA APS
Publication of CN111344281A publication Critical patent/CN111344281A/zh
Application granted granted Critical
Publication of CN111344281B publication Critical patent/CN111344281B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201880065901.5A 2017-08-14 2018-08-13 取代苯并咪唑类的钾通道抑制剂 Active CN111344281B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17020353 2017-08-14
EP17020353.3 2017-08-14
PCT/EP2018/071911 WO2019034603A1 (en) 2017-08-14 2018-08-13 SUBSTITUTED BENZIMIDAZOLES USEFUL AS INHIBITORS OF THE POTASSIUM CHANNEL

Publications (2)

Publication Number Publication Date
CN111344281A CN111344281A (zh) 2020-06-26
CN111344281B true CN111344281B (zh) 2023-11-14

Family

ID=59699444

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880065901.5A Active CN111344281B (zh) 2017-08-14 2018-08-13 取代苯并咪唑类的钾通道抑制剂

Country Status (6)

Country Link
US (1) US11098018B2 (https=)
EP (1) EP3668841A1 (https=)
JP (1) JP7158464B2 (https=)
CN (1) CN111344281B (https=)
CA (1) CA3072648A1 (https=)
WO (1) WO2019034603A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3013237A1 (en) * 2016-02-24 2017-08-31 Acesion Pharma Aps Novel potassium channel inhibitors
EP3672953B1 (en) * 2017-08-23 2021-07-28 Acesion Pharma ApS Benzimidazole derivatives useful as potassium channel inhibitors
WO2022200162A1 (en) * 2021-03-22 2022-09-29 Acecion Pharma Aps Novel potassium channel inhibitors
EP4245753A1 (en) * 2022-03-17 2023-09-20 Acesion Pharma ApS Imidazole derivatives as potassium channel inhibitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856475A (zh) * 2003-09-23 2006-11-01 默克公司 异喹啉钾通道抑制剂
CN1856472A (zh) * 2003-09-23 2006-11-01 默克公司 异喹啉酮钾通道抑制剂
CN104011054A (zh) * 2011-11-15 2014-08-27 森申有限公司 用作钾通道抑制剂的噻吩并和呋喃并嘧啶类和吡啶类

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005268782A1 (en) 2004-08-05 2006-02-09 Neurosearch A/S 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
US7842817B2 (en) 2005-01-11 2010-11-30 Neurosearch A/S 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
WO2008113747A1 (en) * 2007-03-22 2008-09-25 Neurosearch A/S Medicaments useful as potassium channel modulators
WO2013104577A1 (en) 2012-01-11 2013-07-18 Acesion Pharma Aps Benzimidazolyl-acetamide derivatives useful as potassium channel modulators
CA3013237A1 (en) * 2016-02-24 2017-08-31 Acesion Pharma Aps Novel potassium channel inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856475A (zh) * 2003-09-23 2006-11-01 默克公司 异喹啉钾通道抑制剂
CN1856472A (zh) * 2003-09-23 2006-11-01 默克公司 异喹啉酮钾通道抑制剂
CN104011054A (zh) * 2011-11-15 2014-08-27 森申有限公司 用作钾通道抑制剂的噻吩并和呋喃并嘧啶类和吡啶类

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
2-Amino-substituted derivatives of benzimidazoles from 2-isothiocyanato carboxylates;Ľubomír Floch et al.;《Collection of Czechoslovak Chemical Communications》;19891231;第54卷;第206-214页 *
Direct Amination of α-Hydroxy Amides;Ajay L. Chandgude. et al.;《Asian Journal Of Organic Chemistry》;20170517;第6卷;第981-983页 *
Iodoacetic Acid is an Efficient Reagent for the Synthesis of Amino Acid Derived 2-Aminobenzimidazoles;Andrejs Krasikovs et al.;《SYNTHESIS》;20131231;第45卷;第683-693页 *
Microwave Assisted Synthesis of Trifluoro Substituted 2-Aminobenzimidazole Derivatives via Iodoacetic Acid Mediated One-pot Condensation;R. Sriram et al.;《Journal of Heterocyclic Chemistry》;20170701;第55卷;第2440-2446页 *

Also Published As

Publication number Publication date
JP2020530479A (ja) 2020-10-22
EP3668841A1 (en) 2020-06-24
JP7158464B2 (ja) 2022-10-21
CN111344281A (zh) 2020-06-26
WO2019034603A1 (en) 2019-02-21
US11098018B2 (en) 2021-08-24
CA3072648A1 (en) 2019-02-21
US20200216398A1 (en) 2020-07-09

Similar Documents

Publication Publication Date Title
KR100241583B1 (ko) 아미드 작용기를 갖는 인돌린 유도체, 그의 제조방법 및 그를 함유하는 약학적 조성물
CN111344281B (zh) 取代苯并咪唑类的钾通道抑制剂
CN102762534A (zh) 作为钙通道阻断剂的芳基砜衍生物
CN102256944A (zh) 鞘氨醇-1-磷酸受体拮抗剂
JP3506714B2 (ja) １−アリール−２−アシルアミノ−エタン化合物およびニューロキニン特にニューロキニン１アンタゴニストとしてのそれらの用途
CN109153667B (zh) 新型钾通道抑制剂
CN102112451B (zh) 用作趋化因子受体调节剂的二氮杂环庚烷和哌嗪衍生物
CN111372928B (zh) 用作钾通道抑制剂的苯并咪唑衍生物
US12030856B2 (en) Potassium channel inhibitors
JP7853995B2 (ja) 新規カリウムチャネル阻害剤
US11945811B2 (en) Potassium channel inhibitors
KR20070026420A (ko) 베타-２ 작용제로서의 페닐에탄올아민 유도체

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant